Literature DB >> 11665341

A twin study of the etiology of prolonged fatigue and immune activation.

I B Hickie1, A S Bansal, K M Kirk, A R Lloyd, N G Martin.   

Abstract

Risk factors to prolonged fatigue syndromes (PFS) are controversial. Pre-morbid and/or current psychiatric disturbance, and/or disturbed cell-mediated immunity (CMI), have been proposed as etiologic factors. Self-report measures of fatigue and psychologic distress and three in vitro measures of CMI were collected from 124 twin pairs. Crosstwin-crosstrait correlations were estimated for the complete monozygotic (MZ; 79 pairs) and dizygotic (DZ; 45 pairs) twin groups. Multivariate genetic and environmental models were fitted to explore the patterns of covariation between etiologic factors. For fatigue, the MZ correlation was more than double the DZ correlation (0.49 versus 0.16) indicating strong genetic control of familial aggregation. By contrast, for in vitro immune activation measures MZ and DZ correlations were similar (0.49-0.69 versus 0.42-0.53) indicating the etiologic role of shared environments. As small univariate associations were noted between prolonged fatigue and the in vitro immune measures (r = -0.07 to -0.12), multivariate models were fitted. Relevant etiologic factors included: a common genetic factor accounting for 48% of the variance in fatigue which also accounted for 4%, 6% and 8% reductions in immune activation; specific genetic factors for each of the in vitro immune measures; a shared environment factor influencing the three immune activation measures; and, most interestingly, unique environmental influences which increased fatigue but also increased markers of immune activation. PFS that are associated with in vitro measures of immune activation are most likely to be the consequence of current environmental rather than genetic factors. Such environmental factors could include physical agents such as infection and/or psychologic stress.

Entities:  

Mesh:

Year:  2001        PMID: 11665341     DOI: 10.1375/1369052012209

Source DB:  PubMed          Journal:  Twin Res        ISSN: 1369-0523


  8 in total

Review 1.  Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter?

Authors:  Esther Crawley; George Davey Smith
Journal:  Arch Dis Child       Date:  2007-09-05       Impact factor: 3.791

2.  Evidence for a heritable predisposition to Chronic Fatigue Syndrome.

Authors:  Frederick Albright; Kathleen Light; Alan Light; Lucinda Bateman; Lisa A Cannon-Albright
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

3.  Association of chronic fatigue syndrome with human leucocyte antigen class II alleles.

Authors:  J Smith; E L Fritz; J R Kerr; A J Cleare; S Wessely; D L Mattey
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

4.  Cold pressor pain sensitivity in monozygotic twins discordant for chronic fatigue syndrome.

Authors:  Philip M Ullrich; Niloofar Afari; Clemma Jacobsen; Jack Goldberg; Dedra Buchwald
Journal:  Pain Med       Date:  2007-04       Impact factor: 3.750

5.  Chronic fatigue syndrome defies the mind-body-schism of medicine. New perspectives on a multiple realisable developmental systems disorder.

Authors:  Elling Ulvestad
Journal:  Med Health Care Philos       Date:  2008-02-21

6.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study.

Authors:  Kate L Holliday; Gary J Macfarlane; Barbara I Nicholl; Francis Creed; Wendy Thomson; John McBeth
Journal:  J Psychosom Res       Date:  2010-05       Impact factor: 3.006

7.  Twin analyses of fatigue.

Authors:  Ellen Schur; Niloofar Afari; Jack Goldberg; Dedra Buchwald; Patrick F Sullivan
Journal:  Twin Res Hum Genet       Date:  2007-10       Impact factor: 1.587

8.  Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus.

Authors:  Suzanne D Vernon; Toni Whistler; Barbara Cameron; Ian B Hickie; William C Reeves; Andrew Lloyd
Journal:  BMC Infect Dis       Date:  2006-01-31       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.